Kirkwood JM - Search Results

1

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.

Buchbinder EI, Gunturi A, Perritt J, Dutcher J, Aung S, Kaufman HL, Ernstoff MS, Miletello GP, Curti BD, Daniels GA, Patel SP, Kirkwood JM, Hallmeyer S, Clark JI, Gonzalez R, Richart JM, Lutzky J, Morse MA, Sullivan RJ, McDermott DF. Buchbinder EI, et al. Among authors: kirkwood jm. J Immunother Cancer. 2016 Sep 20;4:52. doi: 10.1186/s40425-016-0155-8. eCollection 2016. J Immunother Cancer. 2016. PMID: 27660706 Free PMC article.

2

Plasminogen activator and its inhibitor in cancer patients treated with tumor necrosis factor.

Logan TF, Virji MA, Gooding WE, Bontempo FA, Ernstoff MS, Kirkwood JM. Logan TF, et al. Among authors: kirkwood jm. J Natl Cancer Inst. 1992 Dec 2;84(23):1802-10. doi: 10.1093/jnci/84.23.1802. J Natl Cancer Inst. 1992. PMID: 1433370

3

Interclinician agreement on the recognition of selected gross morphologic features of pigmented lesions. Studies of melanocytic nevi V.

Barnhill RL, Roush GC, Ernstoff MS, Kirkwood JM. Barnhill RL, et al. Among authors: kirkwood jm. J Am Acad Dermatol. 1992 Feb;26(2 Pt 1):185-90. doi: 10.1016/0190-9622(92)70023-9. J Am Acad Dermatol. 1992. PMID: 1552050

4

Comparison of nonfamilial and familial melanoma.

Barnhill RL, Roush GC, Titus-Ernstoff L, Ernstoff MS, Duray PH, Kirkwood JM. Barnhill RL, et al. Among authors: kirkwood jm. Dermatology. 1992;184(1):2-7. doi: 10.1159/000247489. Dermatology. 1992. PMID: 1558990 Review.

5

Granulocytopenia in cancer patients treated in a phase I trial with recombinant human tumor necrosis factor.

Logan TF, Kaplan SS, Bryant JL, Ernstoff MS, Krause JR, Kirkwood JM. Logan TF, et al. Among authors: kirkwood jm. J Immunother (1991). 1991 Apr;10(2):84-95. doi: 10.1097/00002371-199104000-00002. J Immunother (1991). 1991. PMID: 1675121

6

Role of interferons in the therapy of melanoma.

Kirkwood JM, Ernstoff MS. Kirkwood JM, et al. J Invest Dermatol. 1990 Dec;95(6 Suppl):180S-184S. doi: 10.1111/1523-1747.ep12875497. J Invest Dermatol. 1990. PMID: 1701805 Free article. Review.

7

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Among authors: kirkwood jm. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

8

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: kirkwood jm. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

9

Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI.

Roush GC, Barnhill RL, Ernstoff MS, Kirkwood JM. Roush GC, et al. Among authors: kirkwood jm. Br J Cancer. 1991 Aug;64(2):373-6. doi: 10.1038/bjc.1991.310. Br J Cancer. 1991. PMID: 1892767 Free PMC article.

10

Interferon alpha in combination with other biologics: the scientific rationale.

Herberman RB, Ernstoff MS, Kirkwood JM. Herberman RB, et al. Among authors: kirkwood jm. Br J Haematol. 1991 Oct;79 Suppl 1:78-80. doi: 10.1111/j.1365-2141.1991.tb08126.x. Br J Haematol. 1991. PMID: 1931715 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

600 results

Search Page